WHO/UNFPA prequalified since July 2012. Initiated the USFDA approval process in 2012. The product holds the CE marking and is distributed in India, Brazil, Indonesia, The Netherlands, South Africa, Mozambique and Kyryz Republic.
Available in 143 countries and holds CE marking. WHO/UNFPA prequalified since 2007 and USFDA approved in 2009.
Afghanistan, Angola, Anguilla, Antigua, Argentina, Australia, Bahamas, Bangladesh, Barbados Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia, Botswana, Brazil, Burkino Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, China, Colombia, Comoros, Congo, Congo DR, Costa Rica, Cote D'Ivoire, Cyprus, Czech, Denmark, Dijbouti, Dominican Republic, Dominica, East Timor, Ecuador, Egypt, El Salvador, Equitorial Guinea, Eritrea, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Gaza, West Bank, Georgia, Germany, Ghana, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, India, Indonesia, Iran, Israel, Italy, Jamaica, Kazakhstan, Kenya, Kiribati, Korea, Kyrgyzstan, Laos, Lebanon, Lesotho, Liberia, Luxemburg, Macedonia, Madagascar, Malawi, Malaysia, Mali, Mauritania, Mauritius, Mexico, Mongolia, Morrocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Niger, Nigeria, Pakistan, Panama, Papua N'Guinea, Paraguay, Peru, Philippines, Portugal, Rwanda, Sao Tome, Saudi Arabia, Seirra Leone, Senegal, Serbia, Seychelles, Solomon Islands, South Africa, Spain, Sri Lanka, St Kitts, St Lucia, Sudan, Surinam, Swaziland, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor, Togo, Trinidad, Turkey, Turkmenistan, Turks & Caicos, Uganda, United Kingdom, Ukraine, Uruguay, Uzbekistan, Vanauta, Venezuela, Vietnam, Zambia and Zimbabwe
Currently being assessed by Functionality Study II, the results of the study will be part of the product dossier to be submitted for WHO/UNFPA prequalification.
Holds South Africa Bureau of Standards (SABS) certification mark and CE mark. Is approved by the Shanghai Food and Drug Administration. Currently under review for WHO/UNFPA prequalification.
Holds CE marking.
Holds CE marking and is available in the private sector in several countries including South Africa, Brazil and India. Product dossier has been submitted to WHO/UNFPA for prequalification.
Currently being assessed by Functionality Study II the results of the study will be part of the product dossier to be submitted for WHO/UNFPA prequalification.
Currently not available commercially. Expected to reach the market in late 2015, pending regulatory pre-market approvals.
FCMi is part of the Universal Access to Female Condoms Joint Programme (UAFC) and provides market intelligence for those involved or interested in the procurement and supply of female condoms.
One of the goals of UAFC is to increase the variety of quality-assured and affordable female condoms on the market. With the increase in demand and variety of products, it is anticipated that there will be greater competition in the market leading to better affordability.
FCMi supports this goal by providing visitors information on the range of female condoms either on the market or in the advanced stages of development. Further, FCMi seeks to increase market transparency and market responsiveness by providing the latest female condom market intelligence. These activities contribute to our vision of a vibrant market in which a variety of female condoms are available at affordable prices.
FCMi is managed by i+solutions, a partner in the UAFC consortium.
New Delhi April 6th 2016: Manufactured by HLL Lifecare Ltd (HLL) under the brand name 'Velvet', the contraceptive… read more
Seattle, United States, and Shanghai, China, March 3, 2016—The Woman’s Condom, a new female condom designed… read more